ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France SPEAKERS: Daniela Aust, Germany Michel Ducreux, France Claus-Henning Köhne Robert Glynne-Jones, United Kingdom PompiliuPiso, Germany Hans-Rudolf Raab, Germany LEARNING OBJECTIVES To learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings To understand the importance of pathology and histoprognostic factors To learn about the management of patients after progression, side-effects of treatments, and in special situations
Preceptorship Colorectal Cancer Prague Czech Republic July 6-7th 2016 GOALS OF A PRECEPTORSHIP PROGRAM: To update Young Oncologists and Oncologists in training on: Best Clinical Practice Standard of Care State of the Art Evidence-based Medicine ESMO Guidelines Multidisciplinary management of a given tumor type including: Prognostic/Predictive factors from Pathology/Biology/Genetics All therapeutic approaches (Surgery, Radiation? Chemo/targeted therapies ) Toxicty management Strategy/Sequence of treatment Illustrated by case reports and time for discussion between the Faculty and the audience
PRECEPTORSHIP ON COLORECTAL CANCER 6-7 July 2016, Prague, Czech Republic Participants 47 Faculty 8 Total 55 Participants by Country Albania 2 Italy 1 Armenia 1 Montenegro 1 Belarus 1 Poland 2 Brazil 1 Portugal 2 Croatia 2 Romania 8 Denmark 2 Russian Federation 3 Estonia 1 Serbia 1 France 2 Slovenia 1 Georgia 1 Spain 5 Germany 2 Turkey 1 Greece 1 United Kingdom 2 India 3 Uzbekistan 1 Participants by gender Female 26 55.3% Male 21 44.7%
ESMO Preceptorshipprogram Upcomingitems
2016 PRECEPTORSHIPS Date Topic Venue Chair/ Co-Chair Sponsor Expected participants 1 3-5 February 2016 The Christie-Lung Manchester, UK 2 20-21 May 2016 Colorectal Cancer Valencia, Spain 3 10-11 June 2016 Gastric Prague,Czech Republic J-Y. Douillard, R. Califano, F. Blackhall, R. Stahel J-Y. Douillard, A. Cervantes J-Y. Douillard, A. Cervantes BI, Lilly, AZ Actual 100 Servier(sole sponsor) Actual 54 Lilly (sole sponsor) Actual 49 4 23-24 June 2016 Prostate Cancer Prague,Czech Republic A. Horwich, K. Fizazi Bayer, Astellas 60 5 4-5 July 2016 Immuno-Oncology Siena, Italy M. Maio, R. Stahel BMS (sole sponsor) 60 6 6-7 July 2016 Colorectal Cancer Prague,Czech Republic J-Y. Douillard, A. Cervantes Bayer, Lilly 60 7 16-17 September 2016 Breast Cancer Lisbon, Portugal F. Cardoso Celgene(sole sponsor) 60
2016 PRECEPTORSHIPS/2 Date Topic Venue Chair/Co-Chair Sponsor Expected participants 8 30 September-1 st October 2016 Immuno-Oncology Amsterdam, Netherlands J. Haanen, R. Stahel BMS (sole sponsor) 60 9 20-22 October 2016 Gastrointestinal Cancer Singapore J-Y. Douillard, P. Tan (TBC) Bayer, Lilly 60 10 2-3 November 2016 Immuno-Oncology Zürich,Switzerland R. Stahel, A. Curioni BMS (sole sponsor) 60 11 11-12November 2016* Prostate Lugano, Switzerland A. Horwich + co-chair (TBC) Bayer (sole sponsor?) 12 25-26 November2016 Lymphoma Madrid, Spain M. Ghielmini Servier(sole sponsor) 13 25-26 November Colorectal Barcelona A. Cervantes,J-Y. Douillard 14 9-10 December 2016 Immuno-Oncology Madrid, Spain R. Stahel, I. Melero 60 60 Bayer, Lilly 60 BMS (sole sponsor) 60 15 13-14 December 2016 Non-Small-Cell Lung Cancer (NSCLC) Singapore J-Y. Douillard, Tony Mok(TBC) 16 15-16December 2016 Prostate Singapore J. Bellmunt, US, R. Kanesvaran, SG(All TBC) Lilly, BI 60 Astellas 60 *ESO BCY3 conference will take place on 10-12 november 2016 in lugano
2017 PRECEPTORSHIPS PLAN Europe Date Topic Venue Chair/Co-Chair Notes 1 Feb 2017 Supportive Lugano F. Strasser 2 01-03 March 2017 The Christie - Lung Manchester, UK R. Califano &... 3 April Ovarian cancer Prague J. Ledermann 4 April Prostate Prague A. Horwich, K. Fizazi 5 May Colorectal Athens CK. Koehne, JY. Douillard 6 May Immuno- Oncology Amsterdam R. Stahel/J. Haanen? 7 September Breast Lisbon F. Cardoso 8 Late September Gastric Valencia A.Cervantes, C. Lordick 9 October Colorectal Barcelona CH.Koehne, JY. Douillard 10 October Prostate Lugano A. Horwich, K. Fizazi 11 Nov (TBC) Immuno- Oncology Zurich R. Stahel/J. Haanen? 12 Nov- Dec Lymphoma Prague M. Ghielmini *No events in June due to World GI and ASCO
2017 PRECEPTORSHIPS PLAN Asia & Latin America Date Topic Venue Chair/Co-Chair Sponsor Notes 1 November GI (combinedcourse) Asia 2 November NSCLC Asia 3 November Prostate Asia 4 July? Immuno-Oncology Asia 5 July? Immuno-Oncology Latin America TBC 6? Ovarian Asia A. Cervantes, J. Ledermann + Asian? 7? Head & Neck Asia M.Merlano? A.T.C. Chan TBC TBC 8? Bone Health Asia ESMO Asia Congress takes place on on 17-20 November 2017
And more on ESMO.org.
ESMO Open -a new Open Access Oncology journal
Aims & Scope ESMO Open ESMO Open-the European Society for Medical Oncology s online-only, peer-reviewed Open Access journal Editor-in-Chief: Professor Christoph Zielinski, Medical University of Vienna Dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus oninnovative clinical and translational cancer research Article types include original articles, reviews, editorials and correspondence. In addition the journal welcomes study protocols, phase I trials and meta-analyses Strong focus on digital and multimedia content ESMO members receive a discounted publishing charge Published by BMJon behalf of ESMO.
ESMO Open Progress Update Website Traffic Overview Total Sessions 14,542 Users 11,087 Page views 27,135 Bounce rate 65.8% New visitors 74.5% Returning visitors 25.5% Data period (since hard launch): 1 January 20 June 2016 Sessions: A session is the period time a user is actively engaged with your website, app, etc. Users: users that have had at least one session within the selected date range. Includes both new and returning users.
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Valencia, Spain 20-21 May 2016 Enjoythe meeting!